Floatz logo

INTERFERON ALPHA 1B

Interleukin-2

Henan Cancer Hospitalprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

1 Active assets in the Interleukin-2 cohort.

Asset / SponsorPhaseRating
Thalidomide
Henan Cancer Hospital
N/AD

Same molecule, other indications

INTERFERON ALPHA 1B is also rated in:

Maintenance TreatmentDormant
D
Indicative ·
30 / 100
View asset →
Minor Residue DiseaseDormant
D
Indicative ·
30 / 100
View asset →
Interferon-α-1bDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →